Refine Technology, LLC, was founded in 1999 with a vision to develop and bring to market products in the field of animal cell culture. One such product is the ATF System which has become an industry leading, award winning, cell separation system that allows for increased productivity of cell derived biopharmaceuticals. It is currently used by many top biological and pharmaceutical companies in R&D and in the commercial manufacture of certain protein based drugs.
On June 2, 2014, the ATF System product line and related technology was sold to Repligen Corporation. Refine successfully assisted Repligen with the transition of the manufacturing of the ATF System product to Waltham, Massachusetts.
In its newly expanded Pine Brook, NJ facilities, including ISO Class 7 Cleanroom Space, Refine Technology is now developing and bringing to market innovative products for use in bioprocessing and other fields.